SCHEMBL4370629

SCHEMBL4370629

O=C(OO)c1cccc(Cl)c1.O=C(OO)c1cccc(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.64
KDM4E B2RXH2 2/20 0.55
GAA P10253 1/20 0.55
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 2/20 0.53
USP2 O75604 1/20 0.53
ALOX15 P16050 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TDP1 Q9NUW8 1/20 0.50
RAB9A P51151 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CHRM2 P08172 1/20 0.49
CHRM4 P08173 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
ERCC5 P28715 1/20 0.49
FEN1 P39748 1/20 0.49
NPC1 O15118 1/20 0.47
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351761 1.00 PARP1 (0.64) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL1259 1.00 PARP1 (0.64) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL28819341 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL11613703 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL1471300 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
Hydrochloric Acid SCHEMBL8503466 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL11105533 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL31245780 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
SCHEMBL5484641 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1
Hydrogen Peroxide SCHEMBL8452315 0.98 PARP1 (0.62) PARP1KDM4EGAAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11964978-B2 Modulators of STING (stimulator of interferon genes) PFIZER INC. (US) 2024-04-23 US disclosed
EP-4308563-A1 MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) Pfizer Inc. (US) 2024-01-24 EP disclosed
CN-106588745-B A kind of intermediate and its preparation method and application of benzo alkene fluorine bacterium azoles 杭州百昂锐地科技有限公司 2019-06-14 CN disclosed
CN-106588668-A 2-bromine-5-nitro-1,2,3,4-tetrahydro-1,4-methano-naphthalene-9-phenol and preparation method thereof 杭州百昂锐地科技有限公司 2017-04-26 CN disclosed
CN-106588745-A Intermediate of benzovindiflupyr and preparation method and application thereof 杭州百昂锐地科技有限公司 2017-04-26 CN disclosed
EP-2049534-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS Glaxo Group Limited (GB) 2009-04-22 EP disclosed
WO-2008009735-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964978-B2 Modulators of STING (stimulator of interferon genes) STING1, IRF3, CGAS PARP1 1606/4885KDM4E 3884/4885GAA 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.